In a latest study, we described the identification plus the characterization of a brand new atypical opioid receptor with exclusive adverse regulatory properties in direction of opioid peptides.1 Our success showed that ACKR3/CXCR7, hitherto generally known as an atypical scavenger receptor for chemokines CXCL12 and CXCL11, is also a https://josephm445iff8.vblogetin.com/profile